Gina Drobena
Associate Professor
Also affiliated: Arkansas Children's Hospital (2015); American Red Cross (2017)
Faculty Researcher
Pathology, College of Medicine
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Gina Drobena's research focuses on transfusion medicine and apheresis, particularly concerning hematopoietic progenitor cell collection and its impact on cell therapy laboratory services. Her work also investigates emergent therapeutic interventions, such as plasma exchange, in cases of severe adverse events like local anesthetic systemic toxicity. Drobena has published on the effects of collection goals on apheresis procedures and storage facilities, as well as the use of autologous hematopoietic progenitor cell boosts after CAR-T therapy. She collaborates with researchers at the University of Arkansas for Medical Sciences, including Michele Cottler-Fox, Steven R. Post, Mayumi Nakagawa, and Aaron Wyble. Drobena's scholarship metrics include an h-index of 3 with 9 total publications and 18 total citations.
Metrics
- h-index: 3
- Publications: 9
- Citations: 18
Selected Publications
-
Collection of autologous CD34+ hematopoietic progenitor cells (HPC) in multiple myeloma: CD34 + cell collection yield in relation to molecular subtype, karyotype, and FISH results (2026)
-
A ROADMAP FOR LARGE-SCALE CELLULAR THERAPY PRODUCT DISPOSAL (2026)
-
Impact of New Hematopoietic Progenitor Cell Collection Goals on Apheresis and Cell Therapy Laboratory Services (2025)
-
AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELL (HPC) BOOSTS AFTER CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY: IMPACT ON THE CELL THERAPY LABORATORY AND STORAGE FACILITY (2025)
-
Antidote Worse Than the Poison? Emergent Therapeutic Plasma Exchange After Overzealous Intravenous Lipid Emulsion Infusion During Treatment of Local Anesthetic Systemic Toxicity (2025)
-
SMALL CHANGES, BIG SAVINGS: IMPACT OF HEMATOPOIETIC PROGENITOR CELLS APHERESIS COLLECTION GOALS ON THE CELL THERAPY LAB (2024)
-
Plasma failing visual inspection (2017)
-
Utility of Fluorescence Cytometric Cross-Matched Platelets in Severely Alloimmunized Patients (2016)
-
Flow Cytometric Panel-Reactive Antibody Results and the Ability to Find Transfusion-Compatible Platelets after Antibody-Desensitization for Allogeneic Bone Marrow Transplant. (2016)
-
Heparin‐induced thrombocytopenia: a cautionary tale (2015)
Collaboration Network
Top Collaborators
- SMALL CHANGES, BIG SAVINGS: IMPACT OF HEMATOPOIETIC PROGENITOR CELLS APHERESIS COLLECTION GOALS ON THE CELL THERAPY LAB
- AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELL (HPC) BOOSTS AFTER CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY: IMPACT ON THE CELL THERAPY LABORATORY AND STORAGE FACILITY
- A ROADMAP FOR LARGE-SCALE CELLULAR THERAPY PRODUCT DISPOSAL
- SMALL CHANGES, BIG SAVINGS: IMPACT OF HEMATOPOIETIC PROGENITOR CELLS APHERESIS COLLECTION GOALS ON THE CELL THERAPY LAB
- AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELL (HPC) BOOSTS AFTER CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY: IMPACT ON THE CELL THERAPY LABORATORY AND STORAGE FACILITY
- Impact of New Hematopoietic Progenitor Cell Collection Goals on Apheresis and Cell Therapy Laboratory Services
- SMALL CHANGES, BIG SAVINGS: IMPACT OF HEMATOPOIETIC PROGENITOR CELLS APHERESIS COLLECTION GOALS ON THE CELL THERAPY LAB
- AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELL (HPC) BOOSTS AFTER CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY: IMPACT ON THE CELL THERAPY LABORATORY AND STORAGE FACILITY
- A ROADMAP FOR LARGE-SCALE CELLULAR THERAPY PRODUCT DISPOSAL
- SMALL CHANGES, BIG SAVINGS: IMPACT OF HEMATOPOIETIC PROGENITOR CELLS APHERESIS COLLECTION GOALS ON THE CELL THERAPY LAB
- AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELL (HPC) BOOSTS AFTER CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY: IMPACT ON THE CELL THERAPY LABORATORY AND STORAGE FACILITY
- Impact of New Hematopoietic Progenitor Cell Collection Goals on Apheresis and Cell Therapy Laboratory Services
- Antidote Worse Than the Poison? Emergent Therapeutic Plasma Exchange After Overzealous Intravenous Lipid Emulsion Infusion During Treatment of Local Anesthetic Systemic Toxicity
- Antidote Worse Than the Poison? Emergent Therapeutic Plasma Exchange After Overzealous Intravenous Lipid Emulsion Infusion During Treatment of Local Anesthetic Systemic Toxicity
- Antidote Worse Than the Poison? Emergent Therapeutic Plasma Exchange After Overzealous Intravenous Lipid Emulsion Infusion During Treatment of Local Anesthetic Systemic Toxicity
- Antidote Worse Than the Poison? Emergent Therapeutic Plasma Exchange After Overzealous Intravenous Lipid Emulsion Infusion During Treatment of Local Anesthetic Systemic Toxicity
- AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELL (HPC) BOOSTS AFTER CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY: IMPACT ON THE CELL THERAPY LABORATORY AND STORAGE FACILITY
- AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELL (HPC) BOOSTS AFTER CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY: IMPACT ON THE CELL THERAPY LABORATORY AND STORAGE FACILITY
- Impact of New Hematopoietic Progenitor Cell Collection Goals on Apheresis and Cell Therapy Laboratory Services
- Impact of New Hematopoietic Progenitor Cell Collection Goals on Apheresis and Cell Therapy Laboratory Services
- Impact of New Hematopoietic Progenitor Cell Collection Goals on Apheresis and Cell Therapy Laboratory Services
- Impact of New Hematopoietic Progenitor Cell Collection Goals on Apheresis and Cell Therapy Laboratory Services
- Impact of New Hematopoietic Progenitor Cell Collection Goals on Apheresis and Cell Therapy Laboratory Services
Similar Researchers
Based on overlapping research topics